A region of common deletion in 22q13.3 In human glioma associated with astrocytoma progression

International Journal of Cancer

Volumn 85, Issue 3, 2000, Pages 336-339

  Oskam, Niels T ^a   Bijleveld, Engelien H ^a   Hulsebos, Theo J M ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ASTROCYTOMA; CANCER RISK; CARCINOGENESIS; CHROMOSOME 22Q; CHROMOSOME DELETION; DISEASE ASSOCIATION; DISEASE COURSE; GLIOBLASTOMA; GLIOMA; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; NEUROFIBROMATOSIS; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ASTROCYTOMA; AUTORADIOGRAPHY; BLOTTING, SOUTHERN; CHROMOSOMES, HUMAN, PAIR 22; DISEASE PROGRESSION; DNA, NEOPLASM; GLIOBLASTOMA; GLIOMA; HUMANS; LOSS OF HETEROZYGOSITY; MICROSATELLITE REPEATS; OLIGODENDROGLIOMA;

EID: 0033987633     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(20000201)85:3<336::AID-IJC7>3.0.CO;2-9     Document Type: Article

References (31)

1. AKAGI, K., KURAHASHI, H., ARITA, N., HAYAKAWA, T., MONDEN, M., MORI, T., TAKAI, S. and NISHISHO, I., Deletion mapping of the long arm of chromosome 22 in human meningiomas. Int. J. Cancer, 64, 178-162 (1995).
2. ALLIONE, F., EISINGER, F., PARC, P., NOGUCHI, T., SOBOL, H. and BIRNBAUM, D., Loss of heterozygosity at loci from chromosome arm 22q in human sporadic breast carcinomas. Int. J. Cancer, 75, 181-186 (1998).
3. BULSMA, E.K., VOESTEN, A.M.J., BIJLEVELD, E.H., TROOST, D., WESTERVELD, A., MEREL, P., THOMAS, G. and HULSEBOS, T.J.M., Molecular analysis of genetic changes in ependymomas. Genes Chromosomes Cancer, 13, 272-277 (1995).
4. BIRCH, B.D., JOHNSON, J.P., PARSA, A., DESAI, R.D., YOON, J.T., LYCETTE, C.A., LI, Y.M. and BRUCE, J.N., Frequent type 2 neurofibromatosis gene transcript mutations in sporadic intramedullary spinal cord ependymomas. Neurosurgery, 39, 135-140 (1996).
5. BRYAN, E.J., WATSON, R.H., DAVIS, M., HITCHCOCK, A., FOULKES, W.D. and CAMPBELL, I.G., Localization of an ovarian cancer tumor suppressor gene to a 0.5-cM region between D22S284 and CYP2D, on chromosome 22q. Cancer Res., 56, 719-721 (1996).
6. COLLINS, J.E. and 31 others, A high-density YAC contig map of human chromosome 22. Nature (Lond.), 377, 367S-379S (1995).
7. DE VITIS, L.R., TEDDE, A., VITELLI, F., AMMANNATI, F., MENNONNA, P., BONO, P., GRAMMATICO, B., GRAMMATICO, P., RADICE, P., BIGOZZI, U, MONTALI, E. and PAPI, L., Analysis of the neurofibromatosis type 2 gene in different human tumors of neuroectodermal origin. Hum. Genet., 97, 638-641 (1996).
8. DIB, C. and 13 others, A comprehensive genetic map of the human genome based on 5,264 microsatellites. Nature (Lond.), 380, 152-154 (1996).
9. HOANG-XUAN, K., MEREL, P., VEGA, F., HUGOT, J.-P., CORNU, P., DELATTRE, J.-Y., POISSON, M., THOMAS, G. and DELATTRE, O., Analysis of the NF2 tumor-suppressor gene and of chromosome 22 deletions in gliomas. Int. J. Cancer. 60, 478-481 (1995).
10. HULSEBOS, T.J.M., BIJLEVELD, E.H., OSKAM, N.T., WESTERVELD, A., LEENSTRA, S., HOGENDOORN, P.C.W. and BRAS, J., Malignant astrocytoma-derived region of common amplification in chromosomal band 17p12 is frequently amplified in high-grade osteosarcomas. Genes Chromosomes Cancer, 18, 279-285 (1997).
11. HULSEBOS, T.J.M., OSKAM, N.T., TROOST, D., LEENSTRA, S. and BIJLEVELD, E.H., Dynamics of genetic alterations associated with glioma recurrence. Genes Chromosomes Cancer, 23, 153-158 (1998).
12. INK4A, MTS1) and CDK4 genes have frequent mutations of the retinoblastoma gene. Oncogene, 13, 1065-1072 (1996).
13. IIDA, A., KUROSE, K., ISOBE, R., AKIYAMA, F., SAKAMOTO, G., YOSHIMOTO, M., KASUMI, F., NAKAMURA, Y. and EMI, M., Mapping of a new target region of allelic loss to a 2-cM interval at 22q13.1 in primary breast cancer. Genes Chromosomes Cancer, 21, 108-112 (1998).
14. JAMES, C.D., CARLBOM, E., DUMANSKI, J.P., HANSEN, M., NORDENSKJOLD, M., COLLINS, V.P. and CAVENEE, W.K., Clonal genomic alterations in glioma malignancy stages. Cancer Res., 48, 5546-5551 (1988).
15. KLEIHUES, P., Burger, P.C. and scheithauer, B.W. (eds.), Histological typing of tumours of the central nervous system. World Health Organization (2nd ed.). Springer, Berlin, Germany (1993).
16. LEENSTRA, S., TROOST, D., WESTERVELD, A., BOSCH, D.A. and HULSEBOS, T.J.M., Molecular characterization of areas with low grade tumor or satellitosis in human malignant astrocytomas. Cancer Res., 52, 1568-1572 (1992).
17. LIBERMANN, T.A., NUSBAUM, H.R., RAZON, N., KRIS, R., LAX, I., SOREQ, H., WHITTLE, N., WATERFIELD, M.D., ULLRICH, A. and SCHLESSINGER, J., Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin. Nature (Lond.), 313, 144-147 (1985).
18. LI, J. and 16 others, PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science, 275, 1943-1947 (1997).
19. MIYAKAWA, A., WANG, X.-L., NAKANISHI, H., IMAI, F.L., SHIIBA, M., MIYA, T., IMAI, Y. and TANZAWA, H., Allelic loss on chromosome 22 in oral cancer: possibility of the existence of a tumor suppressor gene on 22q13. Int. J. Oncol., 13, 705-709 (1998).
20. MOLLENHAUER, J., WIEMANN, S., SCHEURLEN, W., KORN, B., HAYASHI, Y., WILGENBUS, K.K., VON DEIMLING, A. and POUSTKA, A., DMBT1, a new member of the SRCR superfamily, on chromosome 10q25.-q26.1 is deleted in malignant brain tumours. Nature (Genet.), 17, 32-39 (1997).
21. MUHAMMAD, A.K.M.G., YOSHIMINE, T., MARUNO, M., TOKIYOSHI, K., TAKEMOTO, O. and HAYAKAWA, T., Chromosome 22q allelic losses at microsatellite loci in human astrocytic tumors. Neurol. Med. Chir. (Tokyo), 37, 606-611 (1997).
22. NG, H., LAU, K., TSE, J.Y.M., LO, K., WONG, J.H.C., POON, W. and HUANG, D.P., Combined molecular genetic studies of chromosome 22q and the neurofibromatosis type 2 gene in central nervous system tumors. Neurosurgery, 37, 764-773 (1995).
23. REIFENBERGER, J., REIFENBERGER, G., LIU, L., JAMES, C.D., WECHSLER, W. and COLLINS, V.P., Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p. Amer. J. Pathol., 145, 1175-1190 (1994).
24. REY, J.A., BELLO, M.J., JIMENEZ-LARA, A.M., VAQUERO, J., KUSAK, M.E., DE CAMPOS, J.M., SARASA, J.L. and PESTANA, A., Loss of heterozygosity for distal markers on 22q in human gliomas. Int. J. Cancer, 51, 703-706 (1992).
25. RUBIO, M.-P., CORREA, K.M., RAMESH, V., MACCOLLIN, M.M., JACOBY, L.B., VON DEIMLING, A., GUSELLA, J.F. and LOUIS, D.N., Analysis of the neurofibromatosis 2 gene in human ependymomas and astrocytomas. Cancer Res., 54, 45-47 (1994).
26. RUTTLEDGE, M.H., XIE, Y.-G., HAN, F.-Y., PEYRARD, M., COLLINS, V.P., NORDENSKJOLD, M. and DUMANSKI, J.P., Deletions on chromosome 22 in sporadic meningioma. Genes Chromosomes Cancer, 10, 122-130(1994).
27. SMITH, M.T., LUDWIG, C.L., GODFREY, A.D. and ARMBRUSTMACHER, V.W., Grading of oligodendrogliomas. Cancer, 52, 2107-2114 (1983).
28. STECK, P.A. and 14 others, Identification of a candidate tumour suppressor gene, MMACI, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nature (Genet.), 15, 356-362 (1997).
29. VERSTEEGE, I., SEVENET, N., LANGE, J., ROUSSEAU-MERCK, M.-F., AMBROS, P., HANDGRETINGER, R., AURIAS, A. and DELATTRE, O., Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer. Nature (Lond.), 394, 203-206 (1998).
30. WATKINS, D., RUTTLEDGE, M.H., SARRAZIN, J., RANGARATNAM, S., POISSON, M., DELATTRE, J.-Y. and ROULEAU, G.A., Loss of heterozygosity on chromosome 22 in human gliomas does not inactivate the neurofibromatosis type 2 gene. Cancer Genet. Cytogenet., 92, 73-78 (1996).
31. YANA, I., KURAHASHI, H., NAKAMORI, S., KAMEYAMA, M., NAKAMURA, T., TAKAMI, M., MORI, T., TAKAI, S. and NISHISHO, I., Frequent loss of heterozygosity at telomeric loci on 22q in sporadic colorectal cancers. Int. J. Cancer, 60, 174-177 (1995).